Read + Share
Amedeo Smart
Independent Medical Education
Ahuja D, Yeh KH, Patel SB, Lee HH, et al. Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2026;24:794-804.PMID: 40738278
Email
LinkedIn
Privacy Policy